NCT05852860

Brief Summary

The objective of this trial is to evaluate the effectiveness of "nudges" to clinicians, patients, or both in increasing referral to, and engagement with, tobacco use treatment services (TUTS) for HIV patients versus usual care. This will be a four-arm pragmatic cluster randomized clinical trial. The investigators hypothesize that each of the implementation strategy arms will significantly increase TUTS referral and engagement compared to usual care and that the combination of nudges to clinicians and to patients will be the most effective.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P50-P75 for not_applicable hiv

Timeline
8mo left

Started Dec 2023

Typical duration for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Dec 2023Feb 2027

First Submitted

Initial submission to the registry

May 1, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 10, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

June 1, 2026

Status Verified

May 1, 2026

Enrollment Period

3.2 years

First QC Date

May 1, 2023

Last Update Submit

May 28, 2026

Conditions

Keywords

SmokingHIVTobacco UseNicotine DependenceTobacco Use Treatment ServiceBehavioral Economics

Outcome Measures

Primary Outcomes (2)

  • Rate of referral to tobacco treatment

    Defined as the number of TUTS orders signed in the electronic medical record, divided by the total number of pended orders

    through study completion, up to one year

  • Rate of engagement in tobacco treatment

    Defined as the total number of patients who enroll in a tobacco treatment trial, complete at least one session with a tobacco treatment specialist from the investigators' cessation program, or use a tobacco medication divided by the total number of patients

    through study completion, up to one year

Study Arms (4)

Usual Care

NO INTERVENTION

Clinicians and patients will receive no further interventions beyond usual practice.

Clinician Nudge

EXPERIMENTAL

Clinicians will receive a nudge via a Best Practice Alert within the electronic medical record.

Other: Clinician Nudge

Patient Nudge

EXPERIMENTAL

Patients will receive a message sent through the patient portal or via text.

Other: Patient Nudge

Combined Nudge: Clinician and Patient Nudge

EXPERIMENTAL

Both the clinician nudge and the patient nudge will be used.

Other: Clinician NudgeOther: Patient Nudge

Interventions

The clinician nudge will use the BPA functionality within the electronic medical record to deliver a message with a defaulted option to refer to the health system's tobacco treatment program. Changing the default to "no referral" will require an explanation using the options provided or by entering free text.

Clinician NudgeCombined Nudge: Clinician and Patient Nudge

The patient nudge will deliver a message within 72 hours of a patient's next scheduled clinic visit. The message will be delivered through the Penn patient portal (MyPennMedicine) or by text with security measures for privacy.

Combined Nudge: Clinician and Patient NudgePatient Nudge

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Clinician participants must meet the following criteria for enrollment:
  • Penn Division of Infectious Disease
  • Prescribing authority in Pennsylvania (i.e., physician, nurse practitioner, physician assistant)
  • Clinical oversight of HIV patients for the past six months
  • English-speaking (messages will be in English)
  • Patient participants must be diagnosed with HIV and report current tobacco smoking (self-report daily smoking for last 6 months)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

SmokingTobacco UseTobacco Use Disorder

Condition Hierarchy (Ancestors)

BehaviorSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2023

First Posted

May 10, 2023

Study Start

December 1, 2023

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2027

Last Updated

June 1, 2026

Record last verified: 2026-05

Locations